Novo Nordisk launches Phase 3 clinical trials of CagriSema, prioritizing the development of weight loss indications, significantly superior to Semaglutide
CagriSema Phase 3 clinical trials launched in China
On July 5, 2023, Pharmaceuticals observed that according to the China Drug Clinica...
